Experiment 1306085

Worktypes

PHARMACOLOGY OF COMPOUND - IN VITRO

Compounds isolated

SAPINDOSIDE BHEDERAGENIN,3-O-(3,5-DI-O-ACETYL-ALPHA-L-ARABINOPYRANOSYL)-(1-3-ALPHA-L-RHAMNOPYRANOSYL(1-2)-ALPHA-L-ARABINOPYRANOSIDE:RARASAPONIN IIMUKUROZISAPONIN Y-2HISHOUSHISAPONIN EEHEDERAGENIN,3-O-(2-O-ACETYL-BETA-D-XYLOPYRANOSYL)-(1-3-ALPHA-L-RHAMNOPYRANOSYL(1-2)-ALPHA-L-ARABINOPYRANOSIDE:RARASAPONIN IMUKUROZIOSIDE I-BHISHOUSHISAPONIN AHEDERAGENIN,3-O-ALPHA-L-ARABINOPYRANOSYL-(1-3-ALPHA-L-RHAMNOPYRANOSYL(1-2)-ALPHA-L-ARABINOPYRANOSIDE:RARAOSIDEHEDERAGENIN,3-O-(3,4-DI-O-ACETYL-ALPHA-L-ARABINOPYRANOSYL)-(1-3-ALPHA-L-RHAMNOPYRANOSYL(1-2)-ALPHA-L-ARABINOPYRANOSIDE:HEDERAGENIN,3-O-(2,4-DI-O-ACETYL-ALPHA-L-ARABINOPYRANOSYL)-(1-3-ALPHA-L-RHAMNOPYRANOSYL(1-2)-ALPHA-L-ARABINOPYRANOSIDE:MUKUROZISAPONIN E-1HEDERAGENIN,3-O-(ALPHA-L-ARABINOPYRANOSYL(1-3)-ALPHA-L-RHAMNOPYRANOSYL(1-2)-ALPHA-L-ARABINOPYRANOSIDE:MUKUROZISAPONIN Y-1RARASAPONIN III

Alerts

SEE ARTICLE FOR OTHER TEST RESULTS.

Details

PropertyValue
Pharmacology
LIPASE(PANCREATIC) INHIBITION
OrganismSapindus rarak (SAPINDACEAE)
CitationMORIKAWA,T: XIE,Y: ASAO,Y: OKAMOTO,M: YAMASHITA,C: MURAOKA,O: MATSUDA,H: PONGPIRIYADACHA,Y: YUAN,D: YOSHIKAWA,M:. (2009). OLEANANE-TYPE TRITERPENE OLIGOGLYCOSIDES WITH PANCREATIC LIPASE INHIBITORY ACTIVITY FROM THE PERICARPS OF SAPINDUS RARAK. 70(9)
Amount utilized
Compound isolated
Dose amount100 MICROMOLS
Number3
Qualitative resultACTIVE
Dose expressionIC50